N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide

C24H23N3O — CID 112500611

IUPACN-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide
SMILESO=C(NCCCc1ncc2ccccn12)C(c1ccccc1)c1ccccc1
InChIInChI=1S/C24H23N3O/c28-24(23(19-10-3-1-4-11-19)20-12-5-2-6-13-20)25-16-9-15-22-26-18-21-14-7-8-17-27(21)22/h1-8,10-14,17-18,23H,9,15-16H2,(H,25,28)
InChIKeyRIQOLXJODDUOGM-UHFFFAOYSA-N
MW369.47 g/mol
LogP4.22
Rot. Bonds7

About N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide

N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide (PubChem CID 112500611) has the molecular formula C24H23N3O and a molecular weight of 369.47 g/mol. Its IUPAC name is N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide.

Molecular Properties

Compound NameN-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide
PubChem CID112500611
Molecular FormulaC24H23N3O
Molecular Weight369.47 g/mol
Exact Mass369.18
IUPAC NameN-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide
SMILESO=C(NCCCc1ncc2ccccn12)C(c1ccccc1)c1ccccc1
InChIInChI=1S/C24H23N3O/c28-24(23(19-10-3-1-4-11-19)20-12-5-2-6-13-20)25-16-9-15-22-26-18-21-14-7-8-17-27(21)22/h1-8,10-14,17-18,23H,9,15-16H2,(H,25,28)
InChIKeyRIQOLXJODDUOGM-UHFFFAOYSA-N
XLogP4.22
TPSA46.40 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds7
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500369.47
LogP ≤ 54.22
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(4-chlorophenyl)-N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2-methylpropanamide
CID 110309721
2-(dimethylamino)-N-(2-imidazo[1,5-a]pyridin-3-ylethyl)-2-phenylacetamide
CID 110630830
1-butan-2-yl-3-(3-imidazo[1,5-a]pyridin-3-ylpropyl)urea
CID 110630952
N-(2-imidazo[1,5-a]pyridin-3-ylethyl)-4-methyl-3-phenylpentanamide
CID 110313770
3-(4-fluorophenyl)-N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)propanamide
CID 110630927
N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-3-pyrrol-1-ylbenzamide
CID 110309684
N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-4-methoxy-3-phenylbenzamide
CID 110630969
1-benzoyl-N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)piperidine-4-carboxamide
CID 110309713
N-(imidazo[1,5-a]pyridin-3-ylmethyl)-4-methyl-3-phenylpentanamide
CID 110619655
N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-1-phenylmethanesulfonamide
CID 110292198
N-(2-acetamidoethyl)-3-imidazo[1,5-a]pyridin-3-ylpropanamide
CID 110675061
N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2-(5-phenyl-1,2-oxazol-3-yl)acetamide
CID 110313786

Frequently Asked Questions

What is the IUPAC name of N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide?
The IUPAC name of N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide (CID 112500611) is N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide.
What is the SMILES notation for N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide?
The canonical SMILES for N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide is O=C(NCCCc1ncc2ccccn12)C(c1ccccc1)c1ccccc1.
What is the InChIKey of N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide?
The InChIKey is RIQOLXJODDUOGM-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23N3O/c28-24(23(19-10-3-1-4-11-19)20-12-5-2-6-13-20)25-16-9-15-22-26-18-21-14-7-8-17-27(21)22/h1-8,10-14,17-18,23H,9,15-16H2,(H,25,28).
What are the key properties of N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide?
N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide has a molecular weight of 369.47 g/mol, XLogP of 4.22, 7 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-imidazo[1,5-a]pyridin-3-ylpropyl)-2,2-diphenylacetamide is sourced from PubChem (CID 112500611), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).